IT1281502B1 - USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF - Google Patents

USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF

Info

Publication number
IT1281502B1
IT1281502B1 IT95CA000009A ITCA950009A IT1281502B1 IT 1281502 B1 IT1281502 B1 IT 1281502B1 IT 95CA000009 A IT95CA000009 A IT 95CA000009A IT CA950009 A ITCA950009 A IT CA950009A IT 1281502 B1 IT1281502 B1 IT 1281502B1
Authority
IT
Italy
Prior art keywords
nucleoside
treatment
combination
reverse transcriptase
transcriptase inhibitor
Prior art date
Application number
IT95CA000009A
Other languages
Italian (it)
Inventor
Colla Paolo La
Maria Elena Marongiu
Giovanna Piras
Original Assignee
Sardinian Antiviral Research C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sardinian Antiviral Research C filed Critical Sardinian Antiviral Research C
Priority to IT95CA000009A priority Critical patent/IT1281502B1/en
Publication of ITCA950009A0 publication Critical patent/ITCA950009A0/en
Priority to PCT/EP1996/002540 priority patent/WO1996041634A2/en
Priority to AU63552/96A priority patent/AU6355296A/en
Publication of ITCA950009A1 publication Critical patent/ITCA950009A1/en
Application granted granted Critical
Publication of IT1281502B1 publication Critical patent/IT1281502B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT95CA000009A 1995-06-13 1995-06-13 USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF IT1281502B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT95CA000009A IT1281502B1 (en) 1995-06-13 1995-06-13 USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF
PCT/EP1996/002540 WO1996041634A2 (en) 1995-06-13 1996-06-12 Use of a non-nucleoside reverse transcriptase inhibitor in association with nucleoside inhibitors for the treatment of hiv infection
AU63552/96A AU6355296A (en) 1995-06-13 1996-06-12 Use of a non-nucleoside reverse transcriptase inhibitor in a ssociation with nucleoside inhibitors for the treatment of h iv infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95CA000009A IT1281502B1 (en) 1995-06-13 1995-06-13 USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF

Publications (3)

Publication Number Publication Date
ITCA950009A0 ITCA950009A0 (en) 1995-06-13
ITCA950009A1 ITCA950009A1 (en) 1996-12-13
IT1281502B1 true IT1281502B1 (en) 1998-02-18

Family

ID=11347060

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95CA000009A IT1281502B1 (en) 1995-06-13 1995-06-13 USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF

Country Status (3)

Country Link
AU (1) AU6355296A (en)
IT (1) IT1281502B1 (en)
WO (1) WO1996041634A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA72207C2 (en) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Pharmaceutical formulations of efavirenz and disintegrants providing for increasing dissolution rate and process of manufacturing such tablets or capsules
WO2001007027A2 (en) * 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
MX2012001064A (en) 2009-07-24 2012-07-17 Univ Vanderbilt Isoform selective phospholipase d inhibitors.
US9453017B2 (en) 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
US20140163055A1 (en) * 2012-12-11 2014-06-12 Vanderbilt University Methods and compositions of treating hiv infection

Also Published As

Publication number Publication date
WO1996041634A3 (en) 1997-01-23
ITCA950009A1 (en) 1996-12-13
WO1996041634A2 (en) 1996-12-27
ITCA950009A0 (en) 1995-06-13
AU6355296A (en) 1997-01-09

Similar Documents

Publication Publication Date Title
CY2006007I1 (en) USE OF CGMP-PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF IMPOTENCE
ID19198A (en) HETEROSICLIC METALOPROTEASE INHIBITORS
ID18416A (en) DIHETEROSICLIC METALOPROTEASE INHIBITORS
DE69227227D1 (en) Corrosion inhibitors
SG80631A1 (en) Inhibitors of hiv reverse transcriptase
NO942064D0 (en) inhibitors
NO932127L (en) Imidate derivatives and pharmaceutically useful sulfamates with anticonvulsant action
FI953954A0 (en) HIV reverse transcriptase inhibitors
NO942247D0 (en) Corrosion inhibitor and its use
DK0390317T3 (en) Corrosion inhibitor and its use
IL144349A0 (en) Non-nucleoside reverse transcriptase inhibitors
IT1296985B1 (en) BENZAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
ID17334A (en) LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY
PT1047450E (en) ACE INHIBITOR COMBINATIONS - MMP INHIBITOR
IT1281502B1 (en) USE OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR IN COMBINATION WITH NUCLEOSIDE INHIBITORS FOR THE TREATMENT OF
ITMI982216A0 (en) BENZAZINE DERIVATIVES PHOSPHODIESTERASE INHIBITORS 4
NO922167L (en) AMINODECTS AS CORROSION INHIBITORS
NO941151D0 (en) Linear adhesion inhibitors
NO923339D0 (en) corrosion inhibitors
IT240937Y1 (en) DEVICE FOR DETERMINING THE FORM OF TABLE AFORMA OBJECTS
ITMI910251A1 (en) ANALOGUES OF PHOSPHATIDYLINITITOL INHIBITORS OF PHOSPHOLIPASE C PHOSPHATIDYLINITITOL-SPECIFIC
HK1004659A1 (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
EP1047656A4 (en) Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
NO933726D0 (en) KYNURENINASE INHIBITORS
AU7666496A (en) Structure based design of inhibitors of hiv-1 reverse transcriptase

Legal Events

Date Code Title Description
0001 Granted